Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.
The SNMMI Future Leaders Academy is the most recent addition to the SNMMI leadership development strategy. The SNMMI Future Leaders Academy training focuses on setting a clear plan for increasing leadership abilities by developing the necessary skills and organizational expertise to enhance performance and ultimately evolve into a leader both within the nuclear medicine and molecular imaging community and the society.
The academy will also help you to gain knowledge in fundamental leadership techniques from professionally recognized leadership groups and current SNMMI leaders.
Learn more about the Future Leaders Academy HERE.
The Future Leaders Academy will be held January 25-28, 2018 in conjunction with the SNMMI Mid-Winter Meeting in Orlando, FL. By submitting an application you are affirming your availability on these dates and your willingness to attend the academy. If accepted, it is preferred that you make arrangements to stay for the entire Mid-Winter Meeting.
All applications must be received by September 1, 2017, 5:00 pm (ET)
The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.
For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.
For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.
Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!
In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.
SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.
The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.
SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.
The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.
SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors.
The Nuclear Regulatory Commission (NRC) held their fall meeting of the Advisory Committee on Medical Uses of Isotopes (ACMUI) on September 11 and 12, 2017.
(Government Relations News)
The Journal of Nuclear Medicine’s September supplement shines a spotlight on theranostics and its increasingly important role in delivering precision medicine. Theranostics refers to the combination of a predictive biomarker, identified through diagnostic imaging using radiolabeled ligands, with precise therapy targeted on the now-marked cancer cells. The cancer cells are destroyed, while healthy cells are unharmed.
International Isotopes Inc. has announced that Robert W. Atcher, PhD, MBA, FSNMMI has accepted a position on the company's Board of Directors. Atcher recently retired from Los Alamos National Laboratory where, for over 20 years, he worked on various medical applications for isotopes. He currently serves as president of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF).
SNMMI recommends improvements in the ways that CMS pays hospital outpatient departments for nuclear medicine and molecular imaging procedures.
(Government Relations News)
Access research presentations and popular sessions from the SNMMI 2017 Annual Meeting! Learn more.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
Learn more about books published by the Society of Nuclear Medicine and Molecular Imaging and the Technologist Section.